Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Amyotrophic Lateral Sclerosis Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Amyotrophic Lateral Sclerosis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Amyotrophic Lateral Sclerosis Therapeutics Overall Market Size
2.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size: 2021 VS 2028
2.2 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Amyotrophic Lateral Sclerosis Therapeutics Players in Global Market
3.2 Top Global Amyotrophic Lateral Sclerosis Therapeutics Companies Ranked by Revenue
3.3 Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Amyotrophic Lateral Sclerosis Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Amyotrophic Lateral Sclerosis Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Amyotrophic Lateral Sclerosis Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Amyotrophic Lateral Sclerosis Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Amyotrophic Lateral Sclerosis Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Riluzole
4.1.3 Edaravone (Radicava)
4.1.4 Other
4.2 By Type - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Drugs Store
5.1.4 Other
5.2 By Application - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2028
6.3.2 US Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.3.3 Canada Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.3.4 Mexico Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2028
6.4.2 Germany Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.4.3 France Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.4.4 U.K. Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.4.5 Italy Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.4.6 Russia Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.4.8 Benelux Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2028
6.5.2 China Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.5.3 Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.5.4 South Korea Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.5.6 India Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2028
6.6.2 Brazil Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.6.3 Argentina Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Revenue, 2017-2028
6.7.2 Turkey Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.7.3 Israel Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
6.7.5 UAE Amyotrophic Lateral Sclerosis Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Mitsubishi Tanabe Pharma
7.1.1 Mitsubishi Tanabe Pharma Corporate Summary
7.1.2 Mitsubishi Tanabe Pharma Business Overview
7.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Major Product Offerings
7.1.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Mitsubishi Tanabe Pharma Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Amyotrophic Lateral Sclerosis Therapeutics Major Product Offerings
7.2.4 Sanofi Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Sanofi Key News
7.3 Mylan Pharma
7.3.1 Mylan Pharma Corporate Summary
7.3.2 Mylan Pharma Business Overview
7.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Major Product Offerings
7.3.4 Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Mylan Pharma Key News
7.4 Apotex
7.4.1 Apotex Corporate Summary
7.4.2 Apotex Business Overview
7.4.3 Apotex Amyotrophic Lateral Sclerosis Therapeutics Major Product Offerings
7.4.4 Apotex Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Apotex Key News
7.5 Glemark Generics
7.5.1 Glemark Generics Corporate Summary
7.5.2 Glemark Generics Business Overview
7.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Major Product Offerings
7.5.4 Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Glemark Generics Key News
7.6 Covis Pharma
7.6.1 Covis Pharma Corporate Summary
7.6.2 Covis Pharma Business Overview
7.6.3 Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Major Product Offerings
7.6.4 Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Covis Pharma Key News
7.7 Sun Pharma
7.7.1 Sun Pharma Corporate Summary
7.7.2 Sun Pharma Business Overview
7.7.3 Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Major Product Offerings
7.7.4 Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Sun Pharma Key News
7.8 Lunan Pharma
7.8.1 Lunan Pharma Corporate Summary
7.8.2 Lunan Pharma Business Overview
7.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Major Product Offerings
7.8.4 Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Lunan Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer